Significant Insider Selling Continues at Exelixis (EXEL)

Friday, September 15, 2017 10:15 PM ET

Significant Insider Selling Continues at Exelixis (EXEL)

An insider sold 60,640 shares of Exelixis having a market value of approximately $1,650,014 today, as revealed in a form 4 document filed with the SEC. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 100,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 160,640 shares and have averaged 80,320 shares per transaction over this time period.

The level of buy/sell trading at Exelixis is is greater than the 266 peer company average over the last 90-day period. However, the number of shares per average transaction for Exelixis insider buy-sell trading is very close to the average of the Bio Therapeutic Drugs peer group of companies. This peer group saw 7,660,539 shares purchased and 16,440,105 shares sold resulting in an average of 80,875 shares traded and netting out with company insiders disposing of 29,462 shares on average.

Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data used in creating and writing this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.